MDxHealth is continually improving their subscribers experience
(Thomson Reuters ONE) -
In order to continue receiving MDxHealth's press releases or other Company
information, please click on the link below to select the type and language of
the press releases offered.
www.mdxhealth.com then press the 'subscribe' link at the top right of the page.
We thank you in advance for the interest shown towards our Company.
About MDxHealth
MDxHealth (NYSE Euronext : MDXH) is a molecular diagnostics company based in
Irvine, CA and Liège Belgium and that develops and commercializes advanced
epigenetic tests for cancer assessment and the personalized treatment of
patients. By applying patented DNA methylation platform and biomarkers,
MDxHealth helps to address a large and growing unmet medical need for better
cancer diagnosis and treatment information. For more information visit
http://www.mdxhealth.com.
For more information:
Dr. Jan Groen, CEO Mike Sinclair
MDxHealth Halsin Partners
US: +1 949 812 6979 UK: +44 20 7318 2955
BE: +32 4 364 20 70 Cell: +44 7968 022075
info(at)mdxhealth.com msinclair(at)halsin.com
This press release contains forward-looking statements and estimates with
respect to the anticipated future performance of MDxHealth and the market in
which it operates. Such statements and estimates are based on assumptions and
assessments of known and unknown risks, uncertainties and other factors, which
were deemed reasonable but may not prove to be correct. Actual events are
difficult to predict, may depend upon factors that are beyond the company's
control, and may turn out to be materially different. MDxHealth expressly
disclaims any obligation to update any such forward-looking statements in this
release to reflect any change in its expectations with regard thereto or any
change in events, conditions or circumstances on which any such statement is
based unless required by law or regulation.
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: MdxHealth via Thomson Reuters ONE
[HUG#1653095]
Unternehmensinformation / Kurzprofil:
Datum: 29.10.2012 - 12:59 Uhr
Sprache: Deutsch
News-ID 197205
Anzahl Zeichen: 2747
contact information:
Town:
Liège
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 227 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"MDxHealth is continually improving their subscribers experience"
steht unter der journalistisch-redaktionellen Verantwortung von
MdxHealth (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
